国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mouse Myotubularin-related protein 11 (Mtmr11) CSB-YP661074MO
CSB-EP661074MO
CSB-BP661074MO
CSB-MP661074MO
CSB-EP661074MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Transmembrane and ubiquitin-like domain-containing protein 2 (Tmub2), partial CSB-YP661075MO1
CSB-EP661075MO1
CSB-BP661075MO1
CSB-MP661075MO1
CSB-EP661075MO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Cyclin-dependent kinase 15 (Cdk15) CSB-YP661076MO
CSB-EP661076MO
CSB-BP661076MO
CSB-MP661076MO
CSB-EP661076MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Pyrin domain-containing protein 3 (Pydc3) CSB-YP661077MO
CSB-EP661077MO
CSB-BP661077MO
CSB-MP661077MO
CSB-EP661077MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF326b CSB-YP661078ACAM
CSB-EP661078ACAM
CSB-BP661078ACAM
CSB-MP661078ACAM
CSB-EP661078ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Structural protein ORF653, partial CSB-YP661079ACAM
CSB-EP661079ACAM
CSB-BP661079ACAM
CSB-MP661079ACAM
CSB-EP661079ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF38 CSB-YP661080ACAM
CSB-EP661080ACAM
CSB-BP661080ACAM
CSB-MP661080ACAM
CSB-EP661080ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF161a CSB-YP661081ACAM
CSB-EP661081ACAM
CSB-BP661081ACAM
CSB-MP661081ACAM
CSB-EP661081ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF82 CSB-YP661082ACAM
CSB-EP661082ACAM
CSB-BP661082ACAM
CSB-MP661082ACAM
CSB-EP661082ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Structural protein ORF273 CSB-YP661083ACAM
CSB-EP661083ACAM
CSB-BP661083ACAM
CSB-MP661083ACAM
CSB-EP661083ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF227 CSB-YP661084ACAM
CSB-EP661084ACAM
CSB-BP661084ACAM
CSB-MP661084ACAM
CSB-EP661084ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF220 CSB-YP661085ACAM
CSB-EP661085ACAM
CSB-BP661085ACAM
CSB-MP661085ACAM
CSB-EP661085ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF111 CSB-YP661086ACAM
CSB-EP661086ACAM
CSB-BP661086ACAM
CSB-MP661086ACAM
CSB-EP661086ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus two-tailed virus Uncharacterized protein ORF58 CSB-YP661087ACAM
CSB-EP661087ACAM
CSB-BP661087ACAM
CSB-MP661087ACAM
CSB-EP661087ACAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acorus calamus NAD (P)H-quinone oxidoreductase subunit 1, chloroplastic (ndhA), partial CSB-YP661088ACE1
CSB-EP661088ACE1
CSB-BP661088ACE1
CSB-MP661088ACE1
CSB-EP661088ACE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acorus calamus 30S ribosomal protein S19, chloroplastic (rps19) CSB-YP661089ACE
CSB-EP661089ACE
CSB-BP661089ACE
CSB-MP661089ACE
CSB-EP661089ACE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acorus calamus 30S ribosomal protein S11, chloroplastic (rps11) CSB-YP661090ACE
CSB-EP661090ACE
CSB-BP661090ACE
CSB-MP661090ACE
CSB-EP661090ACE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acorus calamus 50S ribosomal protein L33, chloroplastic (rpl33) CSB-YP661091ACE
CSB-EP661091ACE
CSB-BP661091ACE
CSB-MP661091ACE
CSB-EP661091ACE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acorus calamus Chloroplast envelope membrane protein (cemA), partial CSB-YP661092ACE1
CSB-EP661092ACE1
CSB-BP661092ACE1
CSB-MP661092ACE1
CSB-EP661092ACE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acorus calamus 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP661093ACE
CSB-EP661093ACE
CSB-BP661093ACE
CSB-MP661093ACE
CSB-EP661093ACE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>